Recombinant multi-species RAN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RAN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
RAN (ras-related nuclear protein) is a small GTP binding protein belonging to the RAS superfamily that is essential for the translocation of RNA and proteins through the nuclear pore complex. The RAN protein is also involved in control of DNA synthesis and cell cycle progression. Nuclear localization of RAN requires the presence of regulator of chromosome condensation 1 (RCC1). Mutations in RAN disrupt DNA synthesis. Because of its many functions, it is likely that RAN interacts with several other proteins. RAN regulates formation and organization of the microtubule network independently of its role in the nucleus-cytosol exchange of macromolecules. RAN could be a key signaling molecule regulating microtubule polymerization during mitosis. RCC1 generates a high local concentration of RAN-GTP around chromatin which, in turn, induces the local nucleation of microtubules. RAN is an androgen receptor (AR) coactivator that binds differentially with different lengths of polyglutamine within the androgen receptor. Polyglutamine repeat expansion in the AR is linked to Kennedy's disease (X-linked spinal and bulbar muscular atrophy). RAN coactivation of the AR diminishes with polyglutamine expansion within the AR, and this weak coactivation may lead to partial androgen insensitivity during the development of Kennedy's disease. [provided by RefSeq, Jul 2008]
The Alternative Names of target: ARA24,Androgen receptor-associated protein 24,GTP-binding nuclear protein Ran,GTPase Ran,Gsp1,RAN,Ran,Ras-like protein TC4,Ras-related nuclear protein,TC4
Go
to RAN products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP10845-Ag-1/ GM-Tg-hg-IP10845-Ag-2 | Human RAN protein | Human |
| GM-Tg-rg-IP10845-Ag-1/ GM-Tg-rg-IP10845-Ag-2 | Rat RAN protein | Rat |
| GM-Tg-mg-IP10845-Ag-1/ GM-Tg-mg-IP10845-Ag-2 | Mouse RAN protein | Mouse |
| GM-Tg-cynog-IP10845-Ag-1/ GM-Tg-cynog-IP10845-Ag-2 | Cynomolgus/Rhesus macaque RAN protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP10845-Ag-1/ GM-Tg-felg-IP10845-Ag-2 | Feline RAN protein | Feline |
| GM-Tg-cang-IP10845-Ag-1/ GM-Tg-cang-IP10845-Ag-2 | Canine RAN protein | Canine |
| GM-Tg-bovg-IP10845-Ag-1/ GM-Tg-bovg-IP10845-Ag-2 | Bovine RAN protein | Bovine |
| GM-Tg-equg-IP10845-Ag-1/ GM-Tg-equg-IP10845-Ag-2 | Equine RAN protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP10845-Ag-1/ GM-Tg-hg-IP10845-Ag-2;
GM-Tg-rg-IP10845-Ag-1/ GM-Tg-rg-IP10845-Ag-2;
GM-Tg-mg-IP10845-Ag-1/ GM-Tg-mg-IP10845-Ag-2; GM-Tg-cynog-IP10845-Ag-1/ GM-Tg-cynog-IP10845-Ag-2; GM-Tg-felg-IP10845-Ag-1/ GM-Tg-felg-IP10845-Ag-2; GM-Tg-cang-IP10845-Ag-1/ GM-Tg-cang-IP10845-Ag-2; GM-Tg-bovg-IP10845-Ag-1/ GM-Tg-bovg-IP10845-Ag-2; GM-Tg-equg-IP10845-Ag-1/ GM-Tg-equg-IP10845-Ag-2 |
| Products Name | RAN protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | RAN |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RAN protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.